Ampersand Medical Corp.
This article was originally published in Start Up
Executive Summary
Coming in late to the highly competitive and crowded market for cervical cancer screening, Ampersand Medical is doing something completely different. To remove the subjectivity from interpretation of test restuls, it is developing InPath, a comprehensive screening system that uses a cocktail of protein-based biomolecular markers to identify cellular abnormalities associated with cancers at different stages.